Expression of concern
The HER-2 Receptor and Breast Cancer: Ten Years of Targeted Anti–HER-2 Therapy and Personalized Medicine
Paper Information
Record ID:
9198
Author(s):
Journal:
Publication Date:
April 03, 2009
Retraction Date:
March 01, 2016
(9.7 years years ago)
Subjects:
Institutions:
Country:
🇺🇸 United StatesArticle Type:
Publisher:
Society for Translational Oncology
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Expression of concern Details
Retraction Reasons:
Nature of Retraction:
Expression of concern
Retraction Notice:
10.1634/theoncologist.2016-3001Citations (961)
961
Total Citations451
Post-Retraction(46.9%)
390
Pre-Retraction3
Same DayPost-Retraction Citation Analysis
5
Within 30 days
65
Within 1 year
341
After 2+ years
3306
Days since retraction (latest)
Paper citing The HER-2 Receptor and Breast Cancer: Ten Years of...
Unknown Authors
Unknown Journal
Published: Feb 2024
2893 days after retraction
Paper citing The HER-2 Receptor and Breast Cancer: Ten Years of...
Unknown Authors
Unknown Journal
Published: Feb 2024
2893 days after retraction
Dual-loaded liposomal carriers to combat chemotherapeutic resistance in breast cancer
Mohamed El‐Tanani, Hamdi Nsairat, Alaa A. A. Aljabali et al. (6 authors)
Expert Opinion on Drug Delivery
Published: Jan 2024
8 citations
8 citations
2890 days after retraction
Paper citing The HER-2 Receptor and Breast Cancer: Ten Years of...
Unknown Authors
Unknown Journal
Published: Jan 2024
2862 days after retraction
Paper citing The HER-2 Receptor and Breast Cancer: Ten Years of...
Unknown Authors
Unknown Journal
Published: Jan 2024
2862 days after retraction
Paper citing Vemurafenib in Multiple Nonmelanoma Cancers with B...
Unknown Authors
Unknown Journal
Published: Jan 2024
2862 days after retraction
Paper citing The HER-2 Receptor and Breast Cancer: Ten Years of...
Unknown Authors
Unknown Journal
Published: Dec 2023
2848 days after retraction
Paper citing The HER-2 Receptor and Breast Cancer: Ten Years of...
Unknown Authors
Unknown Journal
Published: Nov 2023
2809 days after retraction
Paper citing The HER-2 Receptor and Breast Cancer: Ten Years of...
Unknown Authors
Unknown Journal
Published: Oct 2023
2770 days after retraction
Paper citing The HER-2 Receptor and Breast Cancer: Ten Years of...
Unknown Authors
Unknown Journal
Published: Sep 2023
2764 days after retraction
Paper citing The HER-2 Receptor and Breast Cancer: Ten Years of...
Unknown Authors
Unknown Journal
Published: Aug 2023
2737 days after retraction
Paper citing The HER-2 Receptor and Breast Cancer: Ten Years of...
Unknown Authors
Unknown Journal
Published: Aug 2023
2736 days after retraction
Paper citing The HER-2 Receptor and Breast Cancer: Ten Years of...
Unknown Authors
Unknown Journal
Published: Aug 2023
2726 days after retraction
Paper citing The HER-2 Receptor and Breast Cancer: Ten Years of...
Unknown Authors
Unknown Journal
Published: Aug 2023
2717 days after retraction
Paper citing The HER-2 Receptor and Breast Cancer: Ten Years of...
Unknown Authors
Unknown Journal
Published: Aug 2023
2709 days after retraction
Surface Functionalization of Gold Nanoparticles for Targeting the Tumor Microenvironment to Improve Antitumor Efficiency
K. Tan, Lionel Lian Aun In, Palanirajan Vijayaraj Kumar
ACS Applied Bio Materials
Published: Jul 2023
30 citations
30 citations
2689 days after retraction
Paper citing The HER-2 Receptor and Breast Cancer: Ten Years of...
Unknown Authors
Unknown Journal
Published: Jul 2023
2684 days after retraction
Paper citing The HER-2 Receptor and Breast Cancer: Ten Years of...
Unknown Authors
Unknown Journal
Published: Jul 2023
2683 days after retraction
Paper citing The HER-2 Receptor and Breast Cancer: Ten Years of...
Unknown Authors
Unknown Journal
Published: Jul 2023
2681 days after retraction
Paper citing The HER-2 Receptor and Breast Cancer: Ten Years of...
Unknown Authors
Unknown Journal
Published: Jul 2023
2678 days after retraction
Paper citing Adjuvant Pertuzumab and Trastuzumab in Early HER2-...
Unknown Authors
Unknown Journal
Published: Jun 2023
2673 days after retraction
Paper citing The HER-2 Receptor and Breast Cancer: Ten Years of...
Unknown Authors
Unknown Journal
Published: Jun 2023
2663 days after retraction
Paper citing Adjuvant Pertuzumab and Trastuzumab in Early HER2-...
Unknown Authors
Unknown Journal
Published: Jun 2023
2648 days after retraction
Paper citing The HER-2 Receptor and Breast Cancer: Ten Years of...
Unknown Authors
Unknown Journal
Published: May 2023
2646 days after retraction
Paper citing The HER-2 Receptor and Breast Cancer: Ten Years of...
Unknown Authors
Unknown Journal
Published: May 2023
2640 days after retraction
Paper citing A First-in-Human Phase I Study of the ATP-Competit...
Unknown Authors
Unknown Journal
Published: May 2023
2639 days after retraction
Paper citing The HER-2 Receptor and Breast Cancer: Ten Years of...
Unknown Authors
Unknown Journal
Published: May 2023
2637 days after retraction
Paper citing The HER-2 Receptor and Breast Cancer: Ten Years of...
Unknown Authors
Unknown Journal
Published: May 2023
2626 days after retraction
Paper citing The HER-2 Receptor and Breast Cancer: Ten Years of...
Unknown Authors
Unknown Journal
Published: May 2023
2617 days after retraction
Paper citing The HER-2 Receptor and Breast Cancer: Ten Years of...
Unknown Authors
Unknown Journal
Published: Apr 2023
2613 days after retraction
Paper citing The HER-2 Receptor and Breast Cancer: Ten Years of...
Unknown Authors
Unknown Journal
Published: Apr 2023
2600 days after retraction
Paper citing The HER-2 Receptor and Breast Cancer: Ten Years of...
Unknown Authors
Unknown Journal
Published: Apr 2023
2600 days after retraction
Paper citing The HER-2 Receptor and Breast Cancer: Ten Years of...
Unknown Authors
Unknown Journal
Published: Apr 2023
2600 days after retraction
Paper citing A First-in-Human Phase I Study of the ATP-Competit...
Unknown Authors
Unknown Journal
Published: Apr 2023
2594 days after retraction
Paper citing The HER-2 Receptor and Breast Cancer: Ten Years of...
Unknown Authors
Unknown Journal
Published: Apr 2023
2592 days after retraction
Paper citing The HER-2 Receptor and Breast Cancer: Ten Years of...
Unknown Authors
Unknown Journal
Published: Apr 2023
2587 days after retraction
Paper citing The HER-2 Receptor and Breast Cancer: Ten Years of...
Unknown Authors
Unknown Journal
Published: Mar 2023
2583 days after retraction
Paper citing The HER-2 Receptor and Breast Cancer: Ten Years of...
Unknown Authors
Unknown Journal
Published: Mar 2023
2568 days after retraction
Paper citing The HER-2 Receptor and Breast Cancer: Ten Years of...
Unknown Authors
Unknown Journal
Published: Mar 2023
2557 days after retraction
Paper citing The HER-2 Receptor and Breast Cancer: Ten Years of...
Unknown Authors
Unknown Journal
Published: Mar 2023
2556 days after retraction
A Review and Meta-analysis on Trastuzumab Resistance in Patients with HER2+ Breast Cancer
Alexandre Holzbach Júnior, Bernardo Perin Cima, Mari Dalva Staffen et al. (5 authors)
Mini-Reviews in Medicinal Chemistry
Published: Feb 2023
2551 days after retraction
Paper citing The HER-2 Receptor and Breast Cancer: Ten Years of...
Unknown Authors
Unknown Journal
Published: Feb 2023
2528 days after retraction
Paper citing The HER-2 Receptor and Breast Cancer: Ten Years of...
Unknown Authors
Unknown Journal
Published: Jan 2023
2523 days after retraction
Paper citing The HER-2 Receptor and Breast Cancer: Ten Years of...
Unknown Authors
Unknown Journal
Published: Jan 2023
2523 days after retraction
Paper citing The HER-2 Receptor and Breast Cancer: Ten Years of...
Unknown Authors
Unknown Journal
Published: Jan 2023
2497 days after retraction
Paper citing The HER-2 Receptor and Breast Cancer: Ten Years of...
Unknown Authors
Unknown Journal
Published: Dec 2022
2481 days after retraction
Paper citing The HER-2 Receptor and Breast Cancer: Ten Years of...
Unknown Authors
Unknown Journal
Published: Dec 2022
2470 days after retraction
Paper citing The HER-2 Receptor and Breast Cancer: Ten Years of...
Unknown Authors
Unknown Journal
Published: Nov 2022
2453 days after retraction
Paper citing The HER-2 Receptor and Breast Cancer: Ten Years of...
Unknown Authors
Unknown Journal
Published: Nov 2022
2452 days after retraction
Paper citing The HER-2 Receptor and Breast Cancer: Ten Years of...
Unknown Authors
Unknown Journal
Published: Nov 2022
2450 days after retraction
Quick Stats
Total Citations:
961
Years Since Retraction:
9.7 years
Open Access:
Yes
Last Checked:
Never